Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 21819-21832

  Jaźwińska Kozuba, Aleksandra ^a   Martens Lobenhoffer, Jens ^b   Kruszelnicka, Olga ^c   Rycaj, Jarosław ^d   Chyrchel, Bernadeta ^e   Surdacki, Andrzej ^e   Bode Böger, Stefanie M ^b  

^a Almed Elektra Medical Center   (Poland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Arginine; Carotid vascular structure; Children; Homoarginine; Ornithine

Indexed keywords

ARGINASE; ARGININE; DIMETHYLARGININASE; HOMOARGININE; ORNITHINE;

ADOLESCENT; ADULT; AGE; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANALYTICAL PARAMETERS; ARGININE TO ORNITHINE RATIO; ARTERIAL WALL THICKNESS; ARTERY MUSCLE; ARTICLE; B SCAN; BLOOD VESSEL PARAMETERS; CHILD; COMMON CAROTID ARTERY; CORRELATION ANALYSIS; ENZYME ACTIVITY; EXTRA MEDIAL THICKNESS; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVASCULAR ULTRASOUND; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ARGININE; CHILD; CHILD, PRESCHOOL; FEMALE; HOMOARGININE; HUMANS; LYSINE; MALE; ORNITHINE; STATISTICS AS TOPIC; TUNICA INTIMA;

EID: 84887193113     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141121819     Document Type: Article

References (57)

1. Ryan, W. L.; Wells, I. C. Homocitrulline and homoarginine synthesis from lysine. Science 1964, 144, 1122-1127.
2. Ryan, W. L.; Barak, A. J.; Johnson, R. J. Lysine, homocitrulline, and homoarginine metabolism by the isolated perfused rat liver. Arch. Biochem. Biophys. 1968, 123, 294-297.
3. Cathelineau, L.; Saudubray, J. M.; Charpentier, C.; Polonovski, C. Letter: The presence of the homoanalogues of substrates of the urea cycle in the presence of argininosuccinate synthetase deficiency. Pediatr. Res. 1974, 8, 857.
4. Levin, B.; Oberholzer, V. G.; Palmer, T. Letter: The high levels of lysine, homocitrulline, and homoarginine found in argininosuccinate synthetase deficiency. Pediatr. Res. 1974, 8, 857-858.
5. Ryan, W. L.; Johnson, R. J.; Dimari, S. Homoarginine synthesis by rat kidney. Arch. Biochem. Biophys. 1969, 131, 521-526.
6. Hernández-Guzmán, G.; Alvarez-Morales, A. Isolation and characterization of the gene coding for the amidinotransferase involved in the biosynthesis of phaseolotoxin in Pseudomonas syringae pv. phaseolicola. Mol. Plant. Microbe Interact. 2001, 14, 545-554.
7. Davids, M.; Ndika, J. D.; Salomons, G. S.; Blom, H. J.; Teerlink, T. Promiscuous activity of arginine: glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett. 2012, 586, 3653-3657.
8. März, W.; Meinitzer, A.; Drechsler, C.; Pilz, S.; Krane, V.; Kleber, M. E.; Fischer, J.; Winkelmann, B. R.; Böhm, B. O.; Ritz, E.; et al. Homoarginine, cardiovascular risk, and mortality. Circulation 2010, 122, 967-975.
9. Valtonen, P.; Laitinen, T.; Lyyra-Laitinen, T.; Raitakari, O. T.; Juonala, M.; Viikari, J. S.; Heiskanen, N.; Vanninen, E.; Punnonen, K.; Heinonen, S. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ. J. 2008, 72, 1879-1884.
10. Saarelainen, H.; Valtonen, P.; Punnonen, K.; Laitinen, T.; Raitakari, O. T.; Juonala, M.; Heiskanen, N.; Lyyra-Laitinen, T.; Viikari, J. S.; Vanninen, E.; et al. Subtle changes in ADMA and L-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation. Clin. Physiol. Funct. Imaging 2008, 28, 120-124.
11. Sourij, H.; Meinitzer, A.; Pilz, S.; Grammer, T. B.; Winkelmann, B. R.; Boehm, B. O.; März, W. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. Atherosclerosis 2011, 218, 220-225.
12. Marescau, B.; Nagels, G.; Possemiers, I.; de Broe, M. E.; Becaus, I.; Billiouw, J. M.; Lornoy, W.; de Deyn, P. P. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism 1997, 46, 1024-1031.
13. Meinitzer, A.; Puchinger, M.; Winklhofer-Roob, B. M.; Rock, E.; Ribalta, J.; Roob, J. M.; Sundl, I.; Halwachs-Baumann, G.; März, W. Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin. Chim. Acta 2007, 384, 141-148.
14. Skilton, M. R.; Serusclat, A.; Sethu, A. H. A. U.; Brun, S.; Bernard, S.; Balkau, B.; Moulin P.; Bonnet, F. Noninvasive measurement of carotid extra-media thickness: Associations with cardiovascular risk factors and intima-media thickness. JACC Cardiovasc. Imaging 2009, 2, 176-182.
15. Skilton, M. R.; Sullivan, T. R.; Ayer, J. G.; Harmer, J. A.; Toelle, B. G.; Webb, K.; Marks, G. B.; Celermajer, D. S. Carotid extra-medial thickness in childhood: Early life effects on the arterial adventitia. Atherosclerosis 2012, 222, 478-482.
16. Heistad, D. D.; Armstrong, M. L.; Marcus, M. L. Hyperemia of the aortic wall in atherosclerotic monkeys. Circ. Res. 1981, 48, 669-675.
17. Kwon, H. M.; Sangiorgi, G.; Ritman, E. L.; McKenna, C.; Holmes D. R., Jr.; Schwartz, R. S.; Lerman, A. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J. Clin. Invest. 1998, 101, 1551-1556.
18. Herrmann, J.; Samee, S.; Chade, A.; Rodriguez Porcel, M.; Lerman, L. O.; Lerman, A. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 447-453.
19. Michel, J. B.; Thaunat, O.; Houard, X.; Meilhac, O.; Caligiuri, G.; Nicoletti, A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1259-1268.
20. Jaźwińska-Kozuba, A.; Martens-Lobenhoffer, J.; Surdacki, A.; Kruszelnicka, O.; Rycaj, J.; Godula-Stuglik, U.; Bode-Böger, S. M. Associations between endogenous dimethylarginines and renal function in healthy children and adolescents. Int. J. Mol. Sci. 2012, 13, 15464-15474.
21. Atzler, D.; Mieth, M.; Maas, R.; Böger, R. H.; Schwedhelm, E. Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879, 2294-2298.
22. Gruber, H. J.; Mayer, C.; Meinitzer, A.; Almer, G.; Horejsi, R.; Möller, R.; Pilz, S.; März, W.; Gasser, R.; Truschnig-Wilders, M.; et al. Asymmetric dimethylarginine (ADMA) is tightly correlated with growth in juveniles without correlations to obesity related disorders. Exp. Clin. Endocrinol. Diabetes 2008, 116, 520-524.
23. Lepage, N.; McDonald, N.; Dallaire, L.; Lambert, M. Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin. Chem. 1997, 43, 2397-2402.
24. Hammarqvist, F.; Angsten, G.; Meurling, S.; Andersson, K.; Wernerman, J. Age-related changes of muscle and plasma amino acids in healthy children. Amino Acids 2010, 39, 359-366.
25. Chobanyan-Jürgens, K.; Fuchs, A. J.; Tsikas, D.; Kanzelmeyer, N.; Das, A. M.; Illsinger, S.; Vaske, B.; Jordan, J.; Lücke, T. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II. Amino Acids 2012, 43, 805-811.
26. Böger, R. H.; Bode-Böger, S. M. The clinical pharmacology of L-arginine. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 79-99.
27. Wu, G.; Bazer, F. W.; Davis, T. A.; Kim, S. W.; Li, P.; Marc Rhoads, J.; Carey Satterfield, M.; Smith, S. B.; Spencer, T. E.; Yin, Y. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009, 37, 153-168.
28. Wyss, M.; Kaddurah-Daouk, R. Creatine and creatinine metabolism. Physiol. Rev. 2000, 80, 1107-1213.
29. McGuire, D. M.; Tormanen, C. D.; Segal, I. S.; Van Pilsum, J. F. The effect of growth hormone and thyroxine on the amount of L-arginine: glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase. J. Biol. Chem. 1980, 255, 1152-1159.
30. Hoberman, H. D.; Sims, E. A.; Engstrom, W. W. The effect of methyltestosterone on the rate of synthesis of creatine. J. Biol. Chem. 1948, 173, 111-116.
31. Hrabák, A.; Bajor, T.; Temesi, A. Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages. Biochem. Biophys. Res. Commun. 1994, 198, 206-212.
32. Cittadini, D.; Pietropaolo, C.; Decristofaro, D.; D'Ayjello Caracciolo, M. In vivo effect of L-lysine on rat liver arginase. Nature 1964, 203, 643-644.
33. Fuentes, J. M.; Campo, M. L.; Soler, G. Kinetics and inhibition by some aminoacids of lactating rat mammary gland arginase. Arch. Int. Physiol. Biochim. Biophys. 1994, 102, 255-258.
34. Santhanam, L.; Christianson, D. W.; Nyhan, D.; Berkowitz, D. E. Arginase and vascular aging. J. Appl. Physiol. 2008, 105, 1632-1642.
35. Pollock, J. S.; Förstermann, U.; Mitchell, J. A.; Warner, T. D.; Schmidt, H. H. H. W.; Nakane, M.; Murad, F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 1991, 88, 10480-10484.
36. Baydoun, A. R.; Emery, P. W.; Pearson, J. D.; Mann, G. E. Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 1990, 173, 940-948.
37. Böger, R. H.; Bode-Böger, S. M.; Tsao, P. S.; Lin, P. S.; Chan, J. R.; Cooke, J. P. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J. Am. Coll. Cardiol. 2000, 36, 2287-2295.
38. Surdacki, A. L-arginine analogs-Inactive markers or active agents in atherogenesis? Cardiovasc. Hematol. Agents Med. Chem. 2008, 6, 302-311.
39. Berkowitz, D. E.; White, R.; Li, D.; Minhas, K. M.; Cernetich, A.; Kim, S.; Burke, S.; Shoukas, A. A.; Nyhan, D.; Champion, H. C.; et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003, 108, 2000-2006.
40. Knowles, R. G.; Palacios, M.; Palmer, R. M.; Moncada, S. Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 1989, 86, 5159-5162.
41. Hecker, M.; Walsh, D. T.; Vane, J. R. On the substrate specificity of nitric oxide synthase. FEBS Lett. 1991, 294, 221-224.
42. Moali, C.; Boucher, J. L.; Sari, M. A.; Stuehr, D. J.; Mansuy, D. Substrate specificity of NO synthases: Detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 1998, 37, 10453-10460.
43. Davids, M.; Teerlink, T. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells. Metabolism 2013, 62, 1455-1461.
44. Morris, S. M., Jr. Recent advances in arginine metabolism: Roles and regulation of the arginases. Br. J. Pharmacol. 2009, 157, 922-930.
45. Ryoo, S.; Gupta, G.; Benjo, A.; Lim, H. K.; Camara, A.; Sikka, G.; Sohi, J.; Santhanam, L.; Soucy, K.; Tuday, E.; et al. Endothelial arginase II: A novel target for the treatment of atherosclerosis. Circ. Res. 2008, 102, 923-932.
46. Kim, J. H.; Bugaj, L. J.; Oh, Y. J.; Bivalacqua, T. J.; Ryoo, S.; Soucy, K. G.; Santhanam, L.; Webb, A.; Camara, A.; Sikka, G.; et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 2009, 107, 1249-1257.
47. Shin, W. S.; Berkowitz, D. E.; Ryoo, S. W. Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice. Exp. Mol. Med. 2012, 44, 594-602.
48. Scalera, F.; Borlak, J.; Beckmann, B.; Martens-Lobenhoffer, J.; Thum, T.; Täger, M.; Bode-Böger, S. M. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1816-1822.
49. Shemyakin, A.; Kövamees, O.; Rafnsson, A.; Böhm, F.; Svenarud, P.; Settergren, M.; Jung, C.; Pernow, J. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 2012, 126, 2943-2950.
50. Dumont, J.; Zureik, M.; Bauters, C.; Grupposo, M. C.; Cottel, D.; Montaye, M.; Hamon, M.; Ducimetière, P.; Amouyel, P.; Brousseau, T. Association of OAZ1 gene polymorphisms with subclinical and clinical vascular events. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2120-2126.
51. Pilz, S.; Meinitzer, A.; Tomaschitz, A.; Kienreich, K.; Dobnig, H.; Schwarz, M.; Wagner, D.; Drechsler, C.; Piswanger-Sölkner, C.; März, W.; et al. Associations of homoarginine with bone metabolism and density, muscle strength and mortality: Cross-sectional and prospective data from 506 female nursing home patients. Osteoporos. Int. 2013, 24, 377-381.
52. Schwartz, G. J.; Muñoz, A.; Schneider, M. F.; Mak, R. H.; Kaskel, F.; Warady, B. A.; Furth, S. L. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 2009, 20, 629-637.
53. Staples, A.; LeBlond, R.; Watkins, S.; Wong, C.; Brandt, J. Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr. Nephrol. 2010, 25, 2321-2326.
54. Martens-Lobenhoffer, J.; Bode-Böger, S. M. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: A step improvement in precision by stable isotope dilution mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 904, 140-143.
55. Martens-Lobenhoffer, J.; Bode-Böger, S. M. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. Clin. Chem. 2006, 52, 488-493.
56. Martens-Lobenhoffer, J.; Postel, S.; Tröger, U.; Bode-Böger, S. M. Determination of ornithine in human plasma by hydrophilic interaction chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 855, 271-275.
57. Touboul, P.-J.; Hennerici, M. G.; Meairs, S.; Adams, H.; Amarenco, P.; Bornstein, N.; Csiba, L.; Desvarieux, M.; Ebrahim, S.; Fatar, M.; et al. Mannheim carotid intima-media thickness consensus (2004-2006). Cerebrovasc. Dis. 2007, 23, 75-80.